Literature DB >> 15860847

Hepatocellular carcinoma: the need for progress.

Melanie B Thomas1, Andrew X Zhu.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15860847     DOI： 10.1200/JCO.2005.03.196

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  147 in total

1.  Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.

Authors:  Daniel L Motola; Peter Caravan; Raymond T Chung; Bryan C Fuchs
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

2.  Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging.

Authors:  Tian Yang; Chuan Lin; Jian Zhai; Song Shi; Min Zhu; Nan Zhu; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-10       Impact factor: 4.553

3.  RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells.

Authors:  Yinghui Fu; Jian Huang; Ke-Sheng Wang; Xin Zhang; Ze-Guang Han
Journal:  Mol Biol Rep       Date:  2010-04-06       Impact factor: 2.316

4.  Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways.

Authors:  FangJun Yuan; Wenbo Zhou; Can Zou; Zhiyun Zhang; Hongsheng Hu; Zongqing Dai; YouShun Zhang
Journal:  Mol Cell Biochem       Date:  2010-06-15       Impact factor: 3.396

5.  Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.

Authors:  Zhipeng Meng; Xiaoqiong Wang; Yichao Gan; Yunfeng Zhang; Hong Zhou; Carl Van Ness; Jun Wu; Guiyu Lou; Hua Yu; Chao He; Rongzhen Xu; Wendong Huang
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

6.  Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.

Authors:  Xian-Feng Shen; Xian-Tao Zeng; Zhi-Yuan Jian; Meng Zhou; Ping Zhou; Min Zhang
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

7.  cis-Terpenones as an effective chemopreventive agent against aflatoxin B1-induced cytotoxicity and TCDD-induced P450 1A/B activity in HepG2 cells.

Authors:  Qibing Zhou; Hang Xie; Lin Zhang; Jennifer K Stewart; Xing-Xing Gu; John J Ryan
Journal:  Chem Res Toxicol       Date:  2006-11       Impact factor: 3.739

8.  The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.

Authors:  Manal M Hassan; Margret R Spitz; Melanie B Thomas; Steven A Curley; Yehuda Z Patt; Jean-Nicolas Vauthey; Katrina Y Glover; Ahmed Kaseb; Richard D Lozano; Adel S El-Deeb; Nga T Nguyen; Steven H Wei; Wenyaw Chan; James L Abbruzzese; Donghui Li
Journal:  J Hepatol       Date:  2008-10-16       Impact factor: 25.083

9.  Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence.

Authors:  Ying-Hong Shi; Wen-Xing Ding; Jian Zhou; Jun-Yi He; Yang Xu; Andrea A Gambotto; Hannah Rabinowich; Jia Fan; Xiao-Ming Yin
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

10.  Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea.

Authors:  Chang-Woo Nam; Jung-Woo Shin; Neung-Hwa Park
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.